About
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal
sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Key Metrics
as of Sep 2026Market Cap9,769 Cr
P/E16.90
Div Yield0.47 %
Book Value₹337.00
52w High₹1,231.00
52w Low₹769.00
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 583.00 | 606.00 | 554.00 | 522.00 | 499.00 | 556.00 | 551.00 | 520.00 | 586.00 | 603.00 | 380.00 | 553.00 | 475.00 |
| Expenses | 522.00 | 531.00 | 472.00 | 460.00 | 431.00 | 488.00 | 477.00 | 464.00 | 520.00 | 492.00 | 378.00 | 514.00 | 420.00 |
| Operating Profit | 61.00 | 74.00 | 81.00 | 62.00 | 67.00 | 68.00 | 74.00 | 55.00 | 66.00 | 111.00 | 1.00 | 38.00 | 56.00 |
| OPM % | 10.00 | 12.00 | 15.00 | 12.00 | 13.00 | 12.00 | 13.00 | 11.00 | 11.00 | 18.00 | 0.40 | 7.00 | 12.00 |
| Other Income | 78.00 | 4.00 | 103.00 | 14.00 | 2.00 | 12.00 | 2.00 | 24.00 | 8.00 | -1.00 | 60.00 | 19.00 | 12.00 |
| Depreciation | 26.00 | 25.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 21.00 | 22.00 | 22.00 | 22.00 | 23.00 | 21.00 |
| Interest | 29.00 | 27.00 | 27.00 | 29.00 | 30.00 | 29.00 | 34.00 | 42.00 | 48.00 | 39.00 | 36.00 | 42.00 | 37.00 |
| Profit before tax | 85.00 | 27.00 | 135.00 | 25.00 | 16.00 | 28.00 | 21.00 | 16.00 | 4.00 | 49.00 | 3.00 | -7.00 | 9.00 |
| Tax % | 14.00 | 38.00 | 10.00 | -26.00 | 19.00 | 43.00 | 30.00 | -5.00 | 33.00 | -6.00 | 112.00 | -1.00 | 12.00 |
| Net Profit | 73.00 | 16.00 | 122.00 | 32.00 | 13.00 | 16.00 | 15.00 | 17.00 | 2.00 | 52.00 | 0.00 | -7.00 | 8.00 |
| EPS in Rs | 7.91 | 1.77 | 13.23 | 3.48 | 1.45 | 1.75 | 1.62 | 1.88 | 0.26 | 5.65 | -0.04 | -0.75 | 0.89 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,180.00 | 2,139.00 | 1,866.00 | 1,854.00 | 1,979.00 | 1,858.00 | 1,692.00 | 1,537.00 | 1,470.00 | 1,382.00 | 2,162.00 | 929.00 |
| Expenses | 1,893.00 | 1,877.00 | 1,715.00 | 1,755.00 | 1,902.00 | 1,698.00 | 1,487.00 | 1,402.00 | 1,271.00 | 1,255.00 | 1,894.00 | 795.00 |
| Operating Profit | 287.00 | 263.00 | 151.00 | 100.00 | 77.00 | 159.00 | 205.00 | 135.00 | 199.00 | 127.00 | 268.00 | 134.00 |
| OPM % | 13.00 | 12.00 | 8.00 | 5.00 | 3.90 | 9.00 | 12.00 | 9.00 | 14.00 | 9.00 | 12.00 | 14.00 |
| Other Income | 121.00 | 2,873.00 | 122.00 | 68.00 | 123.00 | 117.00 | 93.00 | 111.00 | 860.00 | 154.00 | 82.00 | 619.00 |
| Interest | 114.00 | 146.00 | 139.00 | 139.00 | 74.00 | 65.00 | 67.00 | 54.00 | 82.00 | 72.00 | 103.00 | 34.00 |
| Depreciation | 91.00 | 85.00 | 87.00 | 94.00 | 104.00 | 99.00 | 94.00 | 83.00 | 78.00 | 70.00 | 103.00 | 49.00 |
| Profit before tax | 203.00 | 2,905.00 | 46.00 | -65.00 | 22.00 | 112.00 | 136.00 | 109.00 | 899.00 | 139.00 | 145.00 | 669.00 |
| Tax % | 10.00 | 1.00 | 3.00 | -107.00 | -738.00 | 30.00 | 12.00 | -1.00 | 1.00 | 22.00 | 10.00 | 20.00 |
| Net Profit | 184.00 | 2,886.00 | 45.00 | 5.00 | 180.00 | 78.00 | 120.00 | 110.00 | 892.00 | 109.00 | 130.00 | 532.00 |
| EPS in Rs | 19.92 | 313.04 | 4.85 | 0.52 | 20.07 | 8.72 | 13.42 | 12.33 | 99.62 | 12.14 | 14.58 | 89.32 |
| Dividend Payout % | 25.00 | 1.00 | 52.00 | 289.00 | 0.00 | 29.00 | 104.00 | 24.00 | 2.00 | 37.00 | 34.00 | 121.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 92.00 | 92.00 | 92.00 | 90.00 | 90.00 | 90.00 | 90.00 | 90.00 | 90.00 | 89.00 | 89.00 | 60.00 |
| Reserves | 3,191.00 | 3,101.00 | 3,436.00 | 3,365.00 | 3,317.00 | 3,158.00 | 3,069.00 | 3,167.00 | 3,073.00 | 3,143.00 | 3,068.00 | 1,415.00 |
| Borrowings | 1,184.00 | 1,202.00 | 1,688.00 | 1,414.00 | 1,284.00 | 917.00 | 902.00 | 811.00 | 606.00 | 1,608.00 | 1,545.00 | 405.00 |
| Other Liabilities | 928.00 | 636.00 | 687.00 | 750.00 | 743.00 | 1,056.00 | 616.00 | 595.00 | 517.00 | 641.00 | 602.00 | 273.00 |
| Total Liabilities | 5,396.00 | 5,031.00 | 5,902.00 | 5,620.00 | 5,434.00 | 5,221.00 | 4,677.00 | 4,663.00 | 4,285.00 | 5,481.00 | 5,304.00 | 2,152.00 |
| Fixed Assets | 785.00 | 767.00 | 747.00 | 597.00 | 617.00 | 644.00 | 651.00 | 574.00 | 564.00 | 1,194.00 | 984.00 | 394.00 |
| CWIP | 181.00 | 106.00 | 107.00 | 55.00 | 56.00 | 111.00 | 112.00 | 122.00 | 144.00 | 158.00 | 180.00 | 39.00 |
| Investments | 1,868.00 | 1,848.00 | 2,364.00 | 2,492.00 | 2,400.00 | 2,395.00 | 2,171.00 | 2,149.00 | 1,777.00 | 2,520.00 | 2,447.00 | 968.00 |
| Other Assets | 2,561.00 | 2,311.00 | 2,684.00 | 2,476.00 | 2,361.00 | 2,072.00 | 1,743.00 | 1,818.00 | 1,801.00 | 1,609.00 | 1,693.00 | 750.00 |
| Total Assets | 5,396.00 | 5,031.00 | 5,902.00 | 5,620.00 | 5,434.00 | 5,221.00 | 4,677.00 | 4,663.00 | 4,285.00 | 5,481.00 | 5,304.00 | 2,152.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 278.00 | 421.00 | -14.00 | 242.00 | -283.00 | 283.00 | 138.00 | 40.00 | 66.00 | 412.00 | 83.00 | 207.00 |
| Cash from Investing Activity | -69.00 | -138.00 | -69.00 | -183.00 | 19.00 | -276.00 | 63.00 | -166.00 | 433.00 | -883.00 | -1,062.00 | 305.00 |
| Cash from Financing Activity | -199.00 | -370.00 | 93.00 | 11.00 | 251.00 | -49.00 | -204.00 | 123.00 | -707.00 | -67.00 | 1,571.00 | -802.00 |
| Net Cash Flow | 10.00 | -86.00 | 11.00 | 70.00 | -13.00 | -42.00 | -3.00 | -3.00 | -208.00 | -538.00 | 592.00 | -290.00 |
| Free Cash Flow | 116.00 | 264.00 | -89.00 | 161.00 | -350.00 | 196.00 | 68.00 | -42.00 | -127.00 | 170.00 | -185.00 | 139.00 |
| CFO/OP % | 97.00 | 114.00 | -45.00 | 142.00 | -397.00 | 73.00 | 83.00 | 57.00 | 42.00 | 352.00 | 49.00 | 191.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 255.00 | 248.00 | 306.00 | 257.00 | 239.00 | 161.00 | 141.00 | 138.00 | 112.00 | 143.00 | 117.00 | 101.00 |
| Inventory Days | 191.00 | 145.00 | 188.00 | 168.00 | 170.00 | 254.00 | 189.00 | 197.00 | 126.00 | 204.00 | 113.00 | 110.00 |
| Days Payable | 225.00 | 163.00 | 205.00 | 220.00 | 213.00 | 271.00 | 200.00 | 212.00 | 183.00 | 234.00 | 148.00 | 133.00 |
| Cash Conversion Cycle | 220.00 | 230.00 | 289.00 | 205.00 | 196.00 | 144.00 | 130.00 | 123.00 | 55.00 | 112.00 | 82.00 | 77.00 |
| Working Capital Days | 83.00 | 83.00 | 41.00 | 48.00 | 22.00 | 16.00 | -37.00 | -14.00 | 1.00 | -61.00 | 28.00 | 33.00 |
| ROCE % | 5.00 | 5.00 | 2.00 | 2.00 | 2.00 | 4.00 | 5.00 | 4.00 | 24.00 | 5.00 | 6.00 | 9.00 |
Corporate Actions
28 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 31 Jul 2026 | 31 Jul 2026 | — | 5.00 | |
| Dividend | 22 Jul 2025 | 22 Jul 2025 | — | 4.00 | |
| Other | 06 Dec 2024 | 06 Dec 2024 | — | — | Spin Off |
| Other | 06 Dec 2024 | 06 Dec 2024 | — | — | Demerger |
| Dividend | 09 Sep 2024 | 09 Sep 2024 | — | 2.50 | |
| Dividend | 04 Aug 2023 | 04 Aug 2023 | — | 1.50 | |
| Dividend | 05 Aug 2021 | 06 Aug 2021 | — | 2.50 | |
| Dividend | 24 Jul 2020 | 27 Jul 2020 | — | 2.00 | |
| Dividend | 22 Aug 2019 | 23 Aug 2019 | — | 12.00 | |
| Dividend | 19 Jul 2019 | — | — | 3.00 | |
| Dividend | 12 Sep 2018 | — | — | 2.00 | |
| Other | 06 Apr 2018 | 09 Apr 2018 | — | — | Spin Off |
| Other | 06 Apr 2018 | 09 Apr 2018 | — | — | Scheme Of Arrangement |
| Dividend | 07 Sep 2017 | — | — | 4.50 | |
| Dividend | 21 Jul 2016 | — | — | 4.00 | |
| Dividend | 22 Jul 2015 | — | — | 3.00 | |
| Dividend | 16 Oct 2014 | 17 Oct 2014 | — | 105.00 | |
| Dividend | 01 Sep 2014 | — | — | 5.00 | |
| Dividend | 19 Dec 2013 | 20 Dec 2013 | — | 500.00 | |
| Dividend | 30 May 2013 | — | — | 2.00 | |
| Dividend | 14 May 2012 | — | — | 2.00 | |
| Dividend | 18 May 2011 | — | — | 1.50 | |
| Dividend | 21 May 2010 | — | — | 1.50 | |
| Other | 16 Apr 2009 | — | — | — | Annual General Meeting |
| Other | 19 Jun 2008 | — | — | — | Agm |
| Dividend | 12 Jun 2007 | — | — | 2.00 | |
| Dividend | 06 Jun 2006 | — | — | 2.00 | |
| Dividend | 13 Jun 2005 | — | — | 1.50 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update8 Jul from care
-
Rating update26 Dec 2025 from care
-
Rating update2 Jul 2025 from care
-
Rating update31 Mar 2025 from care
-
Rating update13 Mar 2025 from fitch
-
Rating update12 Jul 2024 from care
Conference Calls
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript